GlaxoSmithKline on Thursday said that a pre-clinical analysis of the antibody-based COVID-19 therapy it is developing with US partner Vir has indicated that the drug also works against the new Omicron variant.
Further tests will be carried out on the sotrovimab therapy to firm up the results, GSK said in a statement.
Vaccine effectiveness will likely drop against Omicron: Moderna CEOThe head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been ... Coronavirus
Moderna exec says company could have Omicron booster ready in MarchModerna Inc could have a COVID-19 booster shot targeting the Omicron variant tested and ready to file for US authorization as soon as March, the ... Coronavirus
UAE reports its first case of COVID-19 variant OmicronThe UAE’s Ministry of Health detected on Wednesday the first case of the Omicron variant in the country, state news agency WAM reported.The new ... Coronavirus